معرفی
Kevin J. Anstrom is an Adjunct Professor in the Department of Biostatistics & Bioinformatics at Duke University and a key contributor to the Duke Clinical Research Institute (DCRI). His academic trajectory includes progressive roles at Duke, spanning from Instructor to full Professor, with leadership positions as Chief of Biostatistics and Director of DCRI Biostatistics.
Education:
- Ph.D., North Carolina State University (2002)
- M.S., University of North Carolina, Chapel Hill (1994)
- B.S., Cornell University (1992)
Research Focus: Dr. Anstrom specializes in clinical trial methodology, causal inference, and pragmatic healthcare research. His work emphasizes cardiovascular/pulmonary studies, COVID-19 response, and statistical innovations for complex data analysis, with applications in real-world clinical settings.
Publication Trends: His 413+ publications demonstrate consistent focus on clinical trial design, cardiology outcomes, and statistical methodologies. Recent works (2021–2023) highlight COVID-19 interventions, heart failure therapies, and novel data analysis techniques, reflecting cross-disciplinary collaboration in high-impact medical research.
Grant Leadership: He leads 46 active grants including:
- Edios AG10-304 CM Extension Study (2021–2029)
- PROSPER Pulmonary Training Program (2022–2026)
- HERO Program for COVID-19 healthcare workers (2020–2024)
- TRANSFORM-HF/SPIRRIT trial coordination (2017–2024)
- ACTIV initiatives for COVID-19 thrombosis/immunomodulation (2020–2024)
